Scheme of activation of the therapeutic molecule in cells infected with HCV.
<p>The chimeric molecules are cleaved by HCV NS3/4A protease and the released fragments inhibit propagation of HCV through induction of IFN after translocation into the nucleus (cIRF7) or disruption of the replication complex (cVAP-C), whereas the molecule is stably anchored in the ER within uninfected cells.</p
Chemistry, Infectious Diseases, Virology, activation, therapeutic, cells, infected
DOI identifier: 10.1371/journal.pone.0015967.g003
Sorry, we are unable to provide the full text but you may find it at the